Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock
VS

Stock highlights

Stock comparison highlights
Stock name
Eli LillyRoche Holding
Last price
$1,414.18€436.21
Currency
USD
EUR
$1.2T€349B
44.5826.12
$30.81€16.67
-0.33
$6.690
0.50%0
Sector
HealthHealth
Employees
50,000103,249
Ticker
$LLY€ROP
Primary listing
NYSEXGAT

Performance

CumulativeRolling yearsLump sum investment

Invest in $LLY or €ROP on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.